J Studios AEON Biopharma ( NYSE: AEON ) announced receipt of formal minutes from a recent biosimilar initial advisory meeting with the U.S. Food and Drug Administration for ABP-450 injection as a biosimilar utilizing BOTOX as the reference product.
The purpose of the meeting was to.